Detailed Coverage

Entero Healthcare Solutions FY26 Results

Revenue: ₹6,591.21 crore (FY26)
Net Profit: ₹145.84 crore (FY26)

Reader Takeaway: Strong revenue growth and positive cash flow achieved alongside strategic MedTech expansion.

What just happened

Entero Healthcare Solutions Ltd. announced its financial results for the fiscal year 2025-26 (FY26), reporting a consolidated revenue of ₹6,591.21 crore, a 29.35% increase compared to ₹5,095.78 crore in FY25. The company's net profit after tax also saw a significant jump of 35.75%, reaching ₹145.84 crore from ₹107.43 crore in the previous fiscal year.

Why this matters

The results indicate robust growth driven by both organic and inorganic strategies, with revenue boosted by 13.4% organic and 16% inorganic contributions. A key achievement is the company's transition to a positive operating cash flow of ₹96.20 crore in FY26, a marked improvement from prior periods. This signals strengthening operational efficiency and financial health.

The backstory

Entero Healthcare Solutions operates in the fragmented healthcare distribution sector across India. The company has focused on expanding its network and customer base, serving over 105,300 retail pharmacies and 3,600 hospitals through its 136 warehouses.

What changes now

The company is strategically expanding into the MedTech segment, including diagnostics, medical devices, and orthopaedics. Management projects this vertical to surpass ₹1,000 crore in annualized revenue in FY27, which is expected to enhance overall profit margins. This strategic shift aims to leverage higher-margin opportunities.

Risks to watch

Despite the positive performance, investors should note the risks associated with Entero's acquisition-heavy growth strategy. Failure to effectively integrate the seven acquisitions made in FY26 could impact financial performance. Additionally, the distribution business model carries inherent regulatory and product integrity risks.

Peer comparison

Entero Healthcare Solutions operates in the healthcare distribution segment, a critical but often overlooked part of the value chain. Its pan-India presence and extensive network are key competitive advantages in a fragmented market.

Context metrics (time-bound)

• Net Sales / Revenue FY26: ₹6,591.21 crore (up 29.35% from FY25)
• Net Profit FY26: ₹145.84 crore (up 35.75% from FY25)
• Operating Cash Flow FY26: ₹96.20 crore (positive)
• Retail Pharmacy Customers: 105,300+
• Hospital Customers: 3,600+
• Warehouses: 136

What to track next

Investors will be watching the successful integration of recent acquisitions and the growth trajectory of the MedTech segment. Monitoring margin performance, debt levels, and the impact of the 'Enteropreneur' program on market penetration will be crucial.